Comprehensive counseling for families at risk for hereditary colorectal cancer: Impact on perceptions and distress?

Zeitschrift fur Medizinische Psychologie

Volumn 12, Issue 4, 2003, Pages 157-165

  Keller, Monika ^b   Jost, Ralf ^a  

^a Chirurgische Universitätsklinik ^*

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Attitudes; Cancer worries; Genetic counselling; Genetic testing; Hereditary non polyposis colorectal cancer; Psychological distress

Indexed keywords

EID: 85013572336     PISSN: 09405569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aktan-Collan, K., Haukkala, A., Mecklin, J., Uutela, A. & Kaariainen, H. (2001). Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. International Journal of Cancer, 93, 608-611.
2. Baum, A., Friedman, A.L. & Zakowski, S.G. (1997). Stress and genetic testing for disease risk. Health Psychology, 16, 8-19.
3. Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A. & Hodgson, S. (2002). Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women. British Journal of Cancer, 86, 43-50.
4. Bleiker, E.M.A., Aaronson, N.K., Menko, F.H., Hahn, D.E.E., van Asperen, C.J., Rutgers, E.J.T., ten Kate, L.P. & Leschot, N.J. (1997). Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members. Patient Education and Counselling, 32, 107-116.
5. Brähler, E. & Scheer, J. (1983). Der Gießener Beschwerdebogen (GBB). In Handbuch. Huber: Bern.
6. Bullinger, M., Kirchberger, I. & Ware, J. (1995). Der Deutsche SF-36 Health Survey. Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instrumentes zur Erfassung der gesundheitsbezogenen Lebensqualität. Zeitschrift für Gesundheitswissenschaften, 1, 21-36.
7. Bundesärztekammer. (1998). Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Deutsches Ärzteblatt, 95, B 1120-1127.
8. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M.J.E., Lynch, P., McTiernan, A. & Offit, K. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. Journal of the American Medical Association, 277, 997-1003.
9. Codori, A.M., Hansen, R. & Brandt, J. (1994). Self-selection in predictive testing for Huntington’s disease. American Journal of Medical Genetics, 54, 167-173.
10. Codori, A.-M., Petersen, G.M., Miglioretti, D.L., Larkin, E.K., Bushey, M.T., Young, C., Brensinger, J.D. & al., e. (1999). Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers and Prevention, 8, 345-351.
11. Croyle, R. & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute Monographs, 25, 59-66.
12. Cull, A., Anderson, E., Campbell, S., Mackay, J., Smyth, E. & Steel, M. (1999). The impact of genetic counseling about breast cancer risk on women’s risk perception and levels of distress. British Journal of Cancer, 79, 501-508.
13. De Vos, M., Poppe, B., Delvaux, I., Mortier, G., Claes, K., Messiaen, L. & al, e. (1999). Genetic counselling and testing for hereditary breast and ovarian cancer: the Gent(le) approach. Disease Markers, 15, 191-195.
14. Dorval, M., Farkas, P., Schneider, K. & al., e. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p 53 and BRCA1 testing programs. Journal of Clinical Oncology, 18, 2135-2142.
15. DudokdeWit, A.C., Duivenvoorden, H.J., Passchier, J., Niermeijer, M.F., Tibben, A. & al, e. (1997). The course of distress experienced by people at 50% risk for autosomal dominant inheritable disorder, participating in a predictive testing program. Psychosomatic Medicine, 60, 543-549.
16. DudokdeWit, A.C., Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., Passchier, J. & al., e. (1998a). Predicting adaptation to presymptomatic DNA testing for late onset disorders: Who woll experience distress? Journal of Medical Genetics, 35, 745-754.
17. DudokdeWit, A.C., Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., Passchier, J. & Trijsburg, R.W. (1998b). Distress in individuals facing predictive DNA testing for autosomal dominant inheritable late onset disorders; comparing questionnaire results with in-depth interviews. American Journal of Medical Genetics, 75, 62-74.
18. Herrmann, C. (1997). International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17-41.
19. Hinz, A. & Schwarz, R. (2001). Angst und Depression in der Allgemeinbevölkerung. Psychotherapie, Psychosomatik, Medizinische Psychologie, 51, 193-200.
20. Hopwood, P. (1997). Psychological issues in cancer genetics: current research and future priorities. Patient Education and Counselling, 32, 19-31.
21. Horowitz, M., Wilner, N. & Alvarez, W. (1979). Impact of events scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209-218.
22. Jarvinen, H., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L., Peltomaki, P., De La Chapelle, A. & Mecklin, J. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118, 829-834.
23. Julian-Reynier, C., Eisinger, F., Vennin, P., Chabal, F., Aurran, Y., Nogues, C. & al., e. (1996). Attitudes towards cancer predictive testing and transmission of information to the family. Journal of Medical Genetics, 33, 731-736.
24. Kash, K.M., Holland, J.C., Halper, M.S. & Miller, D.G. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute, 84, 24-30.
25. Kinzler, K.W. & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
26. Lerman, C. & Croyle, R. (1994). Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine, 154, 609-616.
27. Lerman, C., Daly, M., Masny, A. & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843-850.
28. Lerman, C., Hughes, C., Lemon, S.J., Main, D., Snyder, C., Durham, C., Narod, S. & Lynch, H.T. (1998). What you don’t know can hurt you: adverse psychologic effects in members of BRCA2-linked families who decline genetic testing. Journal of Clinical Oncology, 16, 1650-1654.
29. Lerman, C., Hughes, C., Trock, B.J., Myers, R.E., Main, D., Bonney, A. & al., e. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. Journal of the American Medical Association, 281, 1618-1622.
30. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K. & Trock, B. (1996a). BRCA1 testing in families with hereditary breast-ovarian cancer -a prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
31. Lerman, C., Schwartz, M.D., Miller S.M., Daly, M., Sands, C., Rimer, B.K. (1996b) A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level and coping style. Health Psychology, 15, 75-83.
32. Lloyd, S., Watson, M., Waites, B., Meyer, L., Eeles, R., Ebbs, S. & Tylee, A. (1996). Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. British Journal of Cancer, 74, 482-487.
33. Lodder, L., Frets, P., Trijsburg, R., Meijers-Heijboer, E., Klijn, J., Duivenvoorden, H., Tibben, A., Wagner, A., van der Meer, C., van den Ouweland, A. & Niermeijer, M. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics, 98, 15-24.
34. Mangold, E., Friedl, W. & Propping, P. (2000). Erbliches Kolorektales Karzinom - Was kann die molekulargenetische Diagnostik leisten? Onkologe, 6, 465-472.
35. McHorney, C., Ware, J.J. & Raczek, A. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
36. Thewes, B., Meiser, B. & Hickie, J. (2001). Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology, 10, 459-468.
37. Vernon, S.W., Perez, C.A., Gritz, E.R., Peterson, S.K., Amos, C.I., Baile, W.F. & Lynch, P.M. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychology, 16, 73-86.
38. Watson, M., Lloyd, S., Meyer, L., Eeles, R., Ebbs, S. & Murday, V. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer, 79, 868-874.
39. Welkenhuysen, M., Evers-Kiebooms, G., Decruyenaere, M., Claes, E. & Denayer, L. (2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. Journal of Medical Genetics, 38, 540-547.
40. Zigmond, A. & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.
41. Zilberg, N.J., Weiss, D.S. & Horowitz, M.J. (1982). Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. Journal of Consulting and Clinical Psychology, 50, 407-414.